The off-patent drug that could protect us from future COVID-19 variants.

🔹Ursodeoxycholic acid (UDCA) may prevent SARS-CoV-2 infection or reduce COVID-19 severity.

#COVID19 #UDCA

Source: https://www.cam.ac.uk/stories/UDCA-COVID19

Prácticas agronómicas para la conservación de suelos y agua ➡️https://bit.ly/2OjHT5k ⬅️ #conservacion #aulavirtual #suelo #agua #agronomia #clases #cursos pic.twitter.com/1PGR9Ooeif, #UDCA #Colombia

Administración de empresas agrícolas: Factor Trabajo, Capital, Tierra ➡️ https://bit.ly/3fkIhzT ⬅️ #economia #administracion #agronomia #inventario #Contabilidad #agricola #cienciasagrarias #fcagrarias pic.twitter.com/9e6tUT3EAr, #UDCA #Colombia

Looks hopeful, and impressive - a treatment to prevent COVID targeting a receptor, rather than the specific variant of the virus. https://www.cam.ac.uk/stories/UDCA-COVID19 #COVID #UDCA

Off-patent liver disease drug could prevent COVID-19 infection and protect against future variants.

Unique experiments involved 'mini-organs', animal research, donated human organs, volunteers and patients.

Ursodeoxycholic acid (UDCA), an off-patent drug used to treat a form of liver disease known as primary biliary cholangitis, 'turns down' FXR and closes the ACE2 doorway.

https://www.nature.com/articles/s41586-022-05594-0

#Covid19 #BlockInfection #VariantProof #UDCA #UrsodeoxycholicAcid

https://www.sciencedaily.com/releases/2022/12/221205121604.htm